Exclusive

Publication

Byline

Oxford Instruments introduces witec360 Raman Microscope with Hexalight Spectrometer across South East Asia

Singapore, Nov. 4 -- Oxford Instruments has announced the launch of its witec360 Raman microscope with the Hexalight spectrometer, setting a new benchmark in confocal Raman imaging and analysis. The n... Read More


Novo Nordisk launches Wegovy in Hong Kong for weight management

Singapore, Nov. 4 -- Novo Nordisk has announced the launch of Wegovy(R) in Hong Kong, now available at private clinics and selected pharmacies. Clinically proven for long-term weight management,Wegovy... Read More


4DMT and Otsuka ink deal worth $336 M to advance eye disease treatment in APAC

Singapore, Nov. 4 -- 4D Molecular Therapeutics has announced a strategic partnership with Otsuka Pharmaceutical to develop and commercialise 4D-150 for the treatment of wet age-related macular degener... Read More


Australia launches first clinical and commercial-scale viral vector manufacturing facility

Singapore, Nov. 3 -- Australia's first and only clinical and commercial-scale viral vector Contract Development and Manufacturing Organisation (CDMO), has officially opened in Sydney. This milestone m... Read More


Boehringer Ingelheim acquires license of autoimmune drug from Japan's Kyowa Kirin for € 640 M

Singapore, Nov. 3 -- German firm Boehringer Ingelheim has licensed a pre-clinical programme from Japan's Kyowa Kirin to develop a potential first-in-class, small molecule for the treatment of autoimmu... Read More


Roche inks nearly $1 B deal with China's Qyuns Therapeutics for respiratory disease treatment

Singapore, Nov. 3 -- China's Qyuns Therapeutics has entered into a global exclusive collaboration and license agreement with F. Hoffmann-La Roche Ltd, pursuant to which the Company grants Roche the gl... Read More


Everest Medicines inks $89 M deal with NovaBridge for treating eye disorders in Asia

Singapore, Oct. 31 -- Everest Medicines, a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialisation of innovative therapeutics, has acquired an ex... Read More


Thermo Fisher buys Clario for $8.9 B offering deeper clinical insights

Singapore, Oct. 31 -- Thermo Fisher Scientific Inc., the world leader in serving science, has announced a definitive agreement to acquire Clario Holdings, Inc., a leading provider of endpoint data sol... Read More


Australia's Myrio Therapeutics teams up with University of Pennsylvania and NYU to advance solid tumour immunotherapy

Singapore, Oct. 31 -- Australia-based Myrio Therapeutics has announced a collaborative research partnership with the University of Pennsylvania's Perelman School of Medicine and NYU Langone Health, in... Read More


IASO Bio partners with GC Cell to bring CAR-T therapy to Korea

Singapore, Oct. 31 -- Nanjing IASO Biotechnology has signed an agreement with Korea's GC Cell to introduce the CAR-T therapy "Fucaso" (Equecabtagene Autoleucel) to the South Korean market for the trea... Read More